Healthcare Digital March 2022 | Page 49

“ Our strategy , as is Sheba ' s is to lead by innovation . We ' re a very patient-centric company with the goal to ' go beyond the pill ' - adding value to our customers and maximizing treatment results .” A

As the pharmaceutical division of Johnson & Johnson , Janssen focuses on developing innovative molecules for patients in different therapeutic areas , to serve unmet medical needs . This aligns well with Sheba ' s position as one of the world ' s most digitally advanced hospitals .
The Sheba ARC Center ( Accelerate , Redesign , Collaborate ) brings together key players in digital medicine - physicians , researchers , start-ups , investors , and top-tier medical centers with the goal of redesigning healthcare .
“ Our innovation room at ARC physically connects us to the main players there and encourages us all to collaborate ”, said Clive Kaye , Managing Director for Janssen Israel .
" Our strategy - as is Sheba ' s - is to lead by innovation . We ' re a very patient-centric company with the goal to ' go beyond the pill ' - adding value to our customers and maximizing treatment results ”.
Janssen is partnering with Sheba in three key areas :

1 . Supporting promising Israeli digital medicare solutions

2 . Getting valuable insights into the patient ' s journey , using synthetic data

3 . Being on-site at ARC to interact with the main ecosystem players

“ Our partnership with Sheba consists in finding technological solutions , looking at the therapeutic areas where we wish to focus , plus working with researchers and technology partners-usually start-ups ”, said Clive .
He adds : “ We currently focus on some digital health projects including areas such as Psychiatry , Gastroenterology and Oncology ”.
Janssen Conducts research using synthetic data provided by MDClone . Performing research while using such data makes it easier and simpler to locate any event along a patient ' s journey without having to worry about patients ' privacy issues .
Professor Eyal Zimlichman , the Chief Medical Officer as well as the Chief Innovation Officer at Sheba , added : “ Janssen was the first industry partner who we signed . We learned very quickly that they share our audacity about where we want to be .”
Advertisement Feature